RhoA-Rho激酶通路在鼻咽癌细胞的表达

doi:10.3969/j.issn.1000-8535.2015.02.001

摘要/Abstract

摘要： 目的观察鼻咽癌患者癌组织中RhoA蛋白-Rho激酶蛋白表达情况。方法收集增城市人民医院2009年2月—2014年6月耳鼻喉科住院治疗,进行活检的鼻咽癌患者切除标本共62例,包括癌组织及癌旁组织。通过SABC免疫组织化学法检测患者癌组织及癌旁组织中RhoA蛋白-Rho激酶蛋白表达情况。结果鼻咽癌组织RhoA蛋白阳性表达率及Rho激酶蛋白阳性率高于癌旁组织(P=0.00);鼻咽癌癌组织RhoA及Rho激酶表达在年龄及性别分布上无差异,而TNM分期中Ⅲ期+Ⅳ期RhoA及Rho激酶表达阳性率高于Ⅰ期+Ⅱ期患者,同时存在淋巴结转移患者其RhoA及Rho激酶表达阳性率高于未转移患者。结论鼻咽癌患者癌组织中RhoA蛋白及Rho激酶表达阳性率高,TNM分期越高及存在淋巴结转移者其RhoA蛋白及Rho激酶表达阳性率越高。RhoA-Rho激酶信号通路参与了鼻咽癌发生发展的过程。

关键词: RhoA-Rho激酶通路, 鼻咽癌, 辛伐他汀

Abstract: Objective To observe the expression of RhoA-Rho kinase protein in patients with nasopharyngeal carcinoma tissue. Methods Collecting 62 cases of patients with nasopharyngeal carcinoma who hospitalized and hadbiopsyof specimens, including carcinoma tissues and adjacent tissues in department of otolaryngology-head and neck surgery from February 2010 to October 2014. The expression of RhoA-Rho kinase protein in carcinoma tissues and adjacent tissues was detected with SABC immune histochemical method. Results Positive expression rate of nasophryngeal carcinoma tissue RhoA protein and Rho kinase protein was significantly higher than that of adjacent tissues, and there was no obvious difference in age and sex between the expression of nasopharyngeal carcinoma tissue RhoA and Rho kinase(P=0.00), while patients being in the third and fourth periods of TNM stage had a higher positive expression rate of RhoA and Rho kinase than those being in the first and second periods. At the same time, RhoA and Rho kinase positive expression rate in patients with lymph node metastasis was higher than that in those without lymph node metastasis. Conclusion Positive expression rate of RhoA protein and Rho kinase in patients with nasopharyngeal carcinoma. The higher TNM stage is, the higher positive expression rate of RhoA protein and Rho kinase in lymph node metastasis is. RhoA-Rho kinase signaling pathways involved in the occurrence and development of nasopharyngeal carcinoma.

Key words: RhoA-Rho kinase pathway, Nasophryngeal carcinoma, Simvastatin

吴启文, 涂永生, 范绍翀, 张海良. RhoA-Rho激酶通路在鼻咽癌细胞的表达[J]. 广州医药, 2015, 46(2): 1-3.

Wu Qiwen, Tu Yongsheng, Fan Shaocong, Zhang Hailiang. The expression of RhoA-Rho kinase pathway in nasopharyngeal carcinoma cells[J]. Guangzhou Medical Journal, 2015, 46(2): 1-3.

参考文献

[1] 武丹,罗元,姚忠强,等.Rho A和Ezrin蛋白在鼻咽癌组织中的表达及临床意义[J].中国癌症防治杂志,2010,2(4):276-279.
[2] 刘孟忠.鼻咽癌治疗新进展[J].广东医学,2014,35(1):1-4.
[3] Tao Q, Chan AT. Nasopharyngeal carcinoma:molecular path0genesis and tllerapeutic developments[J].Expert Rev Mol Med, 2007,9(12):1-24.
[4] 涂永生,王红艳,李建华,等.辛伐他汀抑制鼻咽癌细胞增殖和亲环素A表达[J].临床医学工程,2009,16(8):1-3.
[5] 张骞,杨跃进,王红,等.RhoA/Rho激酶通路在急性心肌梗死后微环境中的核心作用[J].中华心血管病杂志,2013,41(7):622-625.
[6] 郭素媚,邱萍,杨凤霞,等.护理干预对鼻咽癌放疗患者生活质量的影响[J].哈尔滨医药,2011,31(3):234-235.
[7] 李宇,栾洋,韩继宏,等.浅谈鼻咽癌患者的心理护理[J].哈尔滨医药,2010,30(5):68-68.
[8] 罗德红,周纯武,赵燕风,等.鼻咽癌放疗后复发的CT表现[J].中华放射肿瘤学杂志,2008,17(1):3-6.
[9] Ridley AJ, Schwartz MA, Burridge K,et al. Cell migration:integrating signals from front to back[J].Science, 2003,302(5651):1704-1709.
[10] Xie X, Peng J, Chang X,et al. Activation of RhoA/ROCK regulates NF-κB singaling pathway in experimental diabetic nephropathyP[J]. Mol Cell Endocrinol, 2013,369(1-2):86-97.
[11] 程木秋,霍海洋,张海山,等.RhoA/ROCK信号系统对血管外膜炎症介导的大鼠颈动脉平滑肌细胞增殖和表型变化的影响[J].中国医科大学学报,2012,41(3):220-223.
[12] Peng L, Li Y, Shusterman K, et al. Wnt-RhoA signaling is involved in dental enamel development[J].Eur J Oral Sci, 2011,119 Suppl 1:41-49.
[13] Venkatesh D, Fredette N, Rostama B,et al. RhoA-mediated signaling in Notch-induced senescence-like growth arrest and endothelial barrier dysfunction[J].Arterioscler Thromb Vasc Biol, 2011,31(4):876-882.
[14] Li J, Fan Y, Chen J,et al. Microarray analysis of differentially expressed genes between nasopharyngeal carcinoma cell lines 5-8F and 6-10B[J].Cancer Genet Cytogenet, 2010,196(1):23-30.
[15] 蔡成福,任刚,赵德安,等.Wnt信号传导通路与鼻咽癌的关系[J].国际耳鼻咽喉头颈外科杂志,2012,36(1):19-23.
[16] Jantzen F, Könemann S, Wolff B, et al. Jantzen F. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulaiton of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells[J].J Physiol Pharmacol, 2007,58(3):503-514.
[17] Nohria A, Prsic A, Liu PY, et al. Statins inhibit Rho kinase activity in patients with atherosclerosis[J].Atherosclerosis, 2009,205(2):517-521.
[18] Liu PY, Liu YW, Lin LJ,et al.Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.[J]Circulation, 2009,119(1):131-138.